0001209191-21-004291.txt : 20210120
0001209191-21-004291.hdr.sgml : 20210120
20210120162345
ACCESSION NUMBER: 0001209191-21-004291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaPlaca Anthony
CENTRAL INDEX KEY: 0001453022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 21539023
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-15
0
0000742112
INVACARE CORP
IVC
0001453022
LaPlaca Anthony
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Sr. VP and General Counsel
Common Shares
2021-01-15
4
S
0
7500
9.93
D
75869
D
Employee Stock Option (Right to Buy)
Common Shares
83133
83133
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.805 to $10.22, inclusive. The reporting person undertakes to provide to Invacare Corporation, any security holder of Invacare Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 83,133 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between September 2, 2011 and March 16, 2017, at exercise prices between $12.15 to $24.45 per share, will expire between September 2, 2021 and March 16, 2027, and became exercisable between September 30, 2012 and February 19, 2020.
The current balance reflects the expiration of 12,000 options on August 18, 2020.
/s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission
2021-01-20